Clinical validation of five direct-to-consumer smartwatches to detect atrial fibrillation in a Real-World Cohort of Patients: BASEL Wearable Study

被引：0
|
作者：
Mannhart, D. [1 ]
Hennings, E. [1 ]
Lischer, M. [1 ]
Vogeli, D. [1 ]
de lavallaz, J. Du Fay [1 ]
Knecht, S. [1 ]
Schaer, B. [1 ]
Osswald, S. [1 ]
Kuhne, M. [1 ]
Sticherling, C. [1 ]
Badertscher, P. [1 ]
机构：
[1] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O43
引用
收藏
页码：30S / 30S
页数：1
相关论文
共 50 条
  • [41] Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
    Marston, X. L.
    Wang, R.
    Yeh, Y-C
    Zimmermann, L.
    Ye, X.
    Gao, X.
    Brueggenjuergen, B.
    Unverdorben, M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 346 : 93 - 99
  • [42] Differences between atrial fibrillation diagnosed before and after stroke: A large real-world cohort study
    Chang, Yu-Kang
    Hsu, Chih-Cheng
    Huang, Chi-Ting
    Lien, Chi-Hsun
    Hsu, Hung-Yi
    PLOS ONE, 2024, 19 (08):
  • [43] Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain
    Rodriguez-Bernal, Clara L.
    Sanchez-Saez, Francisco
    Bejarano-Quisoboni, Daniel
    Riera-Arnau, Judit
    Sanfelix-Gimeno, Gabriel
    Hurtado, Isabel
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Effectiveness and Safety of Dabigatran and Warfarin in Real-World US Patients With Non-Valvular Atrial Fibrillation: A Retrospective Cohort Study
    Lauffenburger, Julie C.
    Farley, Joel F.
    Gehi, Anil K.
    Rhoney, Denise H.
    Brookhart, M. Alan
    Fang, Gang
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (04):
  • [45] Real-world adherence for direct oral anticoagulants in anewly diagnosed atrial fibrillation cohort: does the dosing interval matter?
    Pham, Phuong N.
    Brown, Joshua D.
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [46] Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
    Phuong N. Pham
    Joshua D. Brown
    BMC Cardiovascular Disorders, 19
  • [47] Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study
    Anguita Sanchez, Manuel
    Bertomeu Martinez, Vicente
    Ruiz Ortiza, Martin
    Cequier Fillat, Angel
    Roldan Rabadan, Inmaculada
    Muniz Garcia, Javier
    Badimon Maestro, Lina
    Esteve Pastor, Maria Asuncion
    Marin Ortuno, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (01): : 14 - 20
  • [48] Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence
    Melillo, Enrico
    Carbone, Andreina
    Rago, Anna
    Papa, Andrea A.
    Onofrio, Antonio D.
    Nigro, Gerardo
    Golino, Paolo
    Russo, Vincenzo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (03) : 185 - 199
  • [49] The Applicability of Novel Predictor of Intracranial Hemorrhage in Patients With Atrial Fibrillation in the Contemporary Real-World Clinical Practice
    Kataoka, Naoya
    Imamura, Teruhiko
    CLINICAL CARDIOLOGY, 2025, 48 (01)
  • [50] Real-world Difficulties in Conducting a Clinical Trial on Life-Style Modifications in Patients With Atrial Fibrillation
    Mohanty, Sanghamitra
    Trivedi, Chintan
    Gianni, Carola
    Al-Ahmad, Amin
    Burkhardt, John D.
    Horton, Rodney
    Sanchez, Javier
    Hranitzky, Patrick
    Gallinghouse, G. J.
    Della Rocca, Domenico G.
    Di Biase, Luigi
    Natale, Andrea
    CIRCULATION, 2017, 136
12345